Video

Hope for Zoledronic Acid in Breast Cancer?

Publish date: December 15, 2010

 

Updated results for the ABCSG Trial 12 continue to show disease-free and overall survival benefits 2 years after stopping adjuvant endocrine treatment with zoledronic acid, Dr. Michael Gnant explains.

Recommended Reading

Bisphosphonates May Reduce Breast Cancer Risk
MDedge Hematology and Oncology
Zoledronic Acid Fizzles for Breast Cancer
MDedge Hematology and Oncology
Half of Women Don't Get Regular Mammograms
MDedge Hematology and Oncology
Treating Early Breast Cancer
MDedge Hematology and Oncology
Mammography Screening Before Age 50
MDedge Hematology and Oncology
Breast Cancer Evolves
MDedge Hematology and Oncology
Triple-Negative Breast Cancer and BRCA Mutations
MDedge Hematology and Oncology
Shoulder Discomfort
MDedge Hematology and Oncology
Commentary on TEAM Trial
MDedge Hematology and Oncology
SLN Biopsy
MDedge Hematology and Oncology